Market News AIOpen the app

TENX stock news · Tenax Therapeutics, Inc.

Stories about Tenax Therapeutics, Inc. (TENX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for TENX

Follow Tenax Therapeutics, Inc. (TENX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TENX
Free on the App Store and Google Play, or on the web.
  1. Oct 8, 2026, 4:19 PM ET · Market

    Tenax Therapeutics is hitting pause on signing up new patients for its LEVEL-2 clinical trial.

    Neutral

    Tenax is adjusting LEVEL-2 to focus on patients more likely to improve, but enrollment is paused during the change. The benefit is not yet shown, leaving its outlook unchanged.

  2. Oct 8, 2026, 4:18 PM ET · Market

    Tenax Therapeutics, Inc. says it is stopping new sign-ups for its LEVEL-2 clinical trial for now.

    Neutral

    Tenax paused LEVEL-2 enrollment to change who can join, aiming to focus on patients more likely to improve. The possible benefit and study delay leave the outlook unchanged.

  3. Sep 1, 2026, 4:40 AM ET · Market

    Last month highlighted 5 stocks favored by Wall Street's top analysts.

    Neutral

    Analyst downgraded Tenax from Buy to Neutral, but the company reported supportive Phase 3 data—positive and negative facts offset each other.